ropivacaine has been researched along with Adenocarcinoma of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, S; Bang, S; Chung, J; Chung, K; Lee, SM; Yoo, S | 1 |
Beck-Schimmer, B; Borgeat, A; Dull, RO; Minshall, RD; Piegeler, T; Schläpfer, M; Schwartz, DE | 1 |
2 other study(ies) available for ropivacaine and Adenocarcinoma of Lung
Article | Year |
---|---|
The erector spinae plane block for effective analgesia after lung lobectomy: Three cases report.
Topics: Adenocarcinoma of Lung; Adjuvants, Anesthesia; Aged; Analgesia, Patient-Controlled; Anesthetics, Local; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Nerve Block; Pain Management; Pain, Postoperative; Paraspinal Muscles; Pneumonectomy; Ropivacaine; Thoracoscopy; Treatment Outcome; Ultrasonography, Interventional | 2019 |
Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Amides; Anesthetics, Local; Caveolin 1; Cell Movement; Drug Evaluation, Preclinical; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lidocaine; Lung Neoplasms; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Ropivacaine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2015 |